Pharmaceutical Commerce Magazine | For Pharma Industry Executives

Business and Finance
Supply Chain/Logistics

Amazon Pharmacy is here; will it change the retail drug business?

Information Technology
Manufacturing and Packaging

Data systems critical to Covid-19 vaccine

Latest News

View All

Information Technology
Supply Chain/Logistics

Progress on DSCSA compliance slows down in US pharma supply chain

Business and Finance
Supply Chain/Logistics

Puerto Rico is poised for a greater supply chain role

Business and Finance
Information Technology

Supporting pharma’s shift in focus from patient ‘outputs’ to ‘outcomes’

FEATURES

How to prepare a cold chain for looming COVID-19 demands

A smooth distribution process for approved vaccines for COVID-19 will require successful product storage and packaging, seamless cold chain transit, accurate shipping, and reliable storage solutions at the point of care. A kink in the process, such as cold transport

3PL selection as part of product launch process

It might seem that in this world of distancing and delays, working with external partners would be one of the most difficult parts of launching a pharmaceutical product. When it comes to third-party logistics providers (3PLs), however, who are one

Securing disrupted cold chains with temperature-monitoring devices

When it comes to the operation and optimization of supply chains, cold chain products have proven to be a temperamental obstacle. Medical and pharmaceutical companies have relied on temperature-controlled supply chains for several decades to preserve and maintain the usability

A regulatory view on Covid-19 vaccine outlook

Support efforts for the development, registration, and production of vaccines to stem the tide of Covid-19 are, of course, occurring busily on all shores. Pharmaceutical Commerce caught up recently, via email, with UK native and longtime pharma R&D and regulatory

More Than Ever, New Therapies Require Reimbursement Support

(sponsored by RxCrossroads by McKesson) Reimbursement in the specialty therapy arena is complex. In this current environment of heightened competition, rising prices and the growth of highly specialized, complex therapies, biopharma companies need assistance maneuvering the ever-changing landscape of reimbursement

Strategies for effective patient services programs

Patient adherence to therapy continues to be a challenge for pharmaceutical manufacturers. New complex patient journeys and multi-channel brand distribution models make it increasingly difficult to address patient barriers to adherence. Manufacturers continue to spend millions of dollars on patient